These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1439138)

  • 21. Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers.
    Hawley AE; Illum L; Davis SS
    FEBS Lett; 1997 Jan; 400(3):319-23. PubMed ID: 9009222
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Osteoblast-like cell (MC3T3-E1) proliferation on bioerodible polymers: an approach towards the development of a bone-bioerodible polymer composite material.
    Elgendy HM; Norman ME; Keaton AR; Laurencin CT
    Biomaterials; 1993; 14(4):263-9. PubMed ID: 8386557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66.
    Rosas JE; Hernández RM; Gascón AR; Igartua M; Guzman F; Patarroyo ME; Pedraz JL
    Vaccine; 2001 Aug; 19(31):4445-51. PubMed ID: 11483270
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biodegradable injectable implant systems for long term drug delivery using poly (lactic-co-glycolic) acid copolymers.
    Chandrashekar G; Udupa N
    J Pharm Pharmacol; 1996 Jul; 48(7):669-74. PubMed ID: 8866326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation.
    Tunçay M; Caliş S; Kaş HS; Ercan MT; Peksoy I; Hincal AA
    Int J Pharm; 2000 Feb; 195(1-2):179-88. PubMed ID: 10675695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of biodegradable poly(D,L-lactide-co-glycolide) polymers and microspheres.
    Hausberger AG; DeLuca PP
    J Pharm Biomed Anal; 1995 May; 13(6):747-60. PubMed ID: 7669829
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo degradation characteristics of poly(glycerol sebacate).
    Wang Y; Kim YM; Langer R
    J Biomed Mater Res A; 2003 Jul; 66(1):192-7. PubMed ID: 12833446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preparation and characterization of poly-(D,L-lactide-co-glycolide) and poly-(L-lactic acid) microspheres with entrapped pneumotropic bacterial antigens.
    Kofler N; Ruedl C; Klima J; Recheis H; Böck G; Wick G; Wolf H
    J Immunol Methods; 1996 Jun; 192(1-2):25-35. PubMed ID: 8699019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs.
    Johansen P; Moon L; Tamber H; Merkle HP; Gander B; Sesardic D
    Vaccine; 1999 Sep; 18(3-4):209-15. PubMed ID: 10506644
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable triblock copolymer microspheres based on thermosensitive sol-gel transition.
    Kwon YM; Kim SW
    Pharm Res; 2004 Feb; 21(2):339-43. PubMed ID: 15032317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines.
    Jones DH; Partidos CD; Steward MW; Farrar GH
    Behring Inst Mitt; 1997 Feb; (98):220-8. PubMed ID: 9382743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chitin/PLGA blend microspheres as a biodegradable drug-delivery system: phase-separation, degradation and release behavior.
    Mi FL; Lin YM; Wu YB; Shyu SS; Tsai YH
    Biomaterials; 2002 Aug; 23(15):3257-67. PubMed ID: 12102197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biocompatibility of poly (DL-lactide-co-glycolide) microspheres implanted into the brain.
    Emerich DF; Tracy MA; Ward KL; Figueiredo M; Qian R; Henschel C; Bartus RT
    Cell Transplant; 1999; 8(1):47-58. PubMed ID: 10338275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosal immunogenicity elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly (D,L-lactide-co-glycolide) microspheres.
    Allaoui-Attarki K; Fattal E; Pecquet S; Trollé S; Chachaty E; Couvreur P; Andremont A
    Vaccine; 1998 Apr; 16(7):685-91. PubMed ID: 9562687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo characterization of huperzine a loaded microspheres made from end-group uncapped poly(d,l-lactide acid) and poly(d,l-lactide-co-glycolide acid).
    Gao P; Ding P; Xu H; Yuan Z; Chen D; Wei J; Chen D
    Chem Pharm Bull (Tokyo); 2006 Jan; 54(1):89-93. PubMed ID: 16394556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sustained release of mitomycin-C from poly(DL-lactide) /poly(DL-lactide-co-glycolide) films.
    Gümüşderelioglu M; Deniz G
    J Biomater Sci Polym Ed; 2000; 11(10):1039-50. PubMed ID: 11211156
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two methods for quantifying DNA extracted from poly(lactide-co-glycolide) microspheres.
    Barman SP; Lunsford L; Chambers P; Hedley ML
    J Control Release; 2000 Dec; 69(3):337-44. PubMed ID: 11102674
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective immunity against Salmonella typhimurium elicited in mice by oral vaccination with phosphorylcholine encapsulated in poly(DL-lactide-co-glycolide) microspheres.
    Allaoui-Attarki K; Pecquet S; Fattal E; Trollé S; Chachaty E; Couvreur P; Andremont A
    Infect Immun; 1997 Mar; 65(3):853-7. PubMed ID: 9038287
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes.
    De Rosa G; Quaglia F; La Rotonda MI; Appel M; Alphandary H; Fattal E
    J Pharm Sci; 2002 Mar; 91(3):790-9. PubMed ID: 11920765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hydrophilic poly(DL-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells.
    Walter E; Dreher D; Kok M; Thiele L; Kiama SG; Gehr P; Merkle HP
    J Control Release; 2001 Sep; 76(1-2):149-68. PubMed ID: 11532321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.